Eyes that can use light to heal themselves
In Singapore, scientists have drawn from one of nature's oldest innovations — photosynthesis — to address one of humanity's most widespread and underestimated afflictions. Researchers at the National University of Singapore have engineered a spinach-derived technology called LEAF that, when delivered as eye drops, enables corneal cells to use ambient light to produce the very molecules that dry eye disease destroys. For the 1.5 billion people whose daily lives are shadowed by chronic eye pain, blurred vision, and the quiet weight of a condition linked to depression, this convergence of plant biology and human medicine represents a rare moment when nature's deep logic is turned toward healing.
- Dry eye disease is a global crisis hiding in plain sight — 1.5 billion sufferers, billions in economic losses, and existing treatments too costly and side-effect-laden for most to sustain long-term.
- At the cellular level, the disease is a self-reinforcing trap: inflammation generates damaging molecules that overwhelm the eye's natural defenses, which produces more damage in an accelerating cycle.
- NUS researchers broke the cycle by transplanting photosynthetic machinery from spinach into corneal cells, creating nanosized LEAF particles that generate protective NADPH antioxidants whenever light enters the eye.
- In preclinical trials, LEAF eye drops reversed corneal damage to near-healthy levels within five days under ordinary indoor lighting — outperforming Restasis, the current standard of care, with no adverse effects over two months.
- The technology's reach may extend well beyond dry eyes: wherever oxidative stress overwhelms the body and light can penetrate — skin, retina, surface tissues — a version of this plant-borrowed healing may follow.
Inside a laboratory at the National University of Singapore, researchers have done something quietly extraordinary: they have taken the photosynthetic machinery from spinach leaves and coaxed human eye cells into using it. The result is a treatment called LEAF — and it may change how medicine thinks about light, plants, and healing.
Dry eye disease is far more than an irritation. It afflicts over 1.5 billion people worldwide with corneal scarring, chronic pain, light sensitivity, and blurred vision. The condition has been linked to depression and anxiety, and costs the US economy alone nearly $3.84 billion annually. Current drugs like cyclosporine A target inflammation but carry side effects that make long-term use difficult for many patients.
The disease works by overwhelming the eye's natural defenses. Corneal inflammation produces reactive oxygen species — chemically aggressive molecules — faster than healthy cells can neutralize them. The key neutralizing compound is NADPH, and dry eye disease steadily depletes it, creating a damaging cycle that feeds itself.
Associate Professor David Leong Tai Wei and his NUS team looked to plants for a different answer. They extracted the thylakoid grana — the light-harvesting structures inside chloroplasts — from spinach, refined them into nanosized 400-nanometer packages, and engineered LEAF to produce NADPH when exposed to light. No device, no power source, no special lamp required — only the ambient light that already enters the eye.
The results were striking. In inflamed cell cultures, LEAF restored NADPH within 30 minutes of light exposure. In tear samples from dry eye patients, it increased NADPH roughly twentyfold and reduced a key cell-damaging oxidant by more than 95 percent. In preclinical trials with ophthalmologists from Zhejiang University, LEAF eye drops reversed corneal damage to near-healthy levels within five days — outperforming Restasis — with no adverse effects observed over two months.
The researchers believe the implications reach beyond the eye. Oxidative stress underlies inflammation across many conditions, and anywhere light can access the body — skin, retina, surface tissues — LEAF-based approaches may prove useful. The team is also exploring ways to deliver similar benefits to internal organs without requiring visible light.
Published in Cell on May 15, 2026, the study now moves toward clinical trials. The concept it carries is both ancient and new: the same process that has powered life on Earth for billions of years, borrowed from a common vegetable, repurposed so that human eyes might use light not only to see — but to heal.
Somewhere in a laboratory at the National University of Singapore, researchers have taken something from the spinach plant and put it into human eye cells. The result is strange and promising: eyes that can use light to heal themselves.
Dry eye disease is not a minor inconvenience. It affects more than 1.5 billion people worldwide, and for many of them it means corneal scarring, chronic pain, blurred vision, and a sensitivity to light that makes ordinary days difficult. The condition has been linked to depression and anxiety. It costs the United States economy alone roughly $3.84 billion each year. The existing treatments—drugs like cyclosporine A and lifitegrast—work by targeting inflammation, but they are expensive and often come with side effects that make long-term use impractical.
At the cellular level, dry eye disease operates like a trap. Inflammation in the cornea produces reactive oxygen species, chemically aggressive molecules that damage cells. Healthy eyes can neutralize these molecules by producing a compound called NADPH. But in inflamed eyes, the reactive oxygen species overwhelm the cornea's natural defenses, creating more damage, which creates more reactive oxygen species—a cycle that feeds itself.
Associate Professor David Leong Tai Wei and his team at NUS decided to approach the problem differently. They looked at how plants harvest sunlight and convert it into chemical energy. They extracted the thylakoid grana—the molecular machinery inside plant chloroplasts where photosynthesis happens—from spinach leaves, stripped away the parts that would be unnecessary in an animal cell, and engineered what they call LEAF: a nanosized package roughly 400 nanometers across, small enough for cells to absorb. When exposed to light, LEAF produces NADPH, the very molecule that dry eye disease depletes. The team used a patented extraction method they developed themselves, turning ordinary spinach into a therapeutic tool.
In laboratory tests on inflamed cells, LEAF restored NADPH levels within 30 minutes of light exposure. When tested in tear samples from patients with dry eye disease, it increased NADPH levels roughly twentyfold and reduced hydrogen peroxide—a key cell-damaging oxidant—by more than 95 percent. In preclinical trials conducted with ophthalmologists from Zhejiang University, the technology, delivered as simple eye drops under normal indoor lighting, reversed corneal damage to near-healthy levels within five days. It outperformed Restasis, the standard treatment. Safety assessments showed no adverse effects over two months of testing.
What makes this approach remarkable is its simplicity. The treatment requires no external device, no power source, no special light. It uses the ambient light that already enters the eye for vision. It comes from a plant most people eat. The mechanism is borrowed directly from nature—the same process that has powered life on Earth for billions of years, now repurposed to heal human tissue.
The researchers see potential beyond dry eye disease. Oxidative stress, the underlying problem that LEAF addresses, drives inflammation in many conditions. Anywhere the body's antioxidant defenses are overwhelmed and light can reach—the retina, the skin, the muscles beneath the skin—LEAF-based approaches might work. The team is also developing strategies to produce therapeutic molecules in internal organs without requiring visible light to penetrate.
The study was published in Cell on May 15, 2026. Clinical trials are planned. For now, the idea remains in the preclinical stage, but the possibility is clear: human cells acquiring a limited, beneficial form of photosynthesis. Eyes that can use light not just to see, but to heal themselves.
Citas Notables
For the first time, we have demonstrated that plant photosynthetic machinery can be transplanted into mammalian tissue to generate biologically useful molecules, powered entirely by the same light that enables our vision.— Dr. Xing Kuoran, first author of the study
With LEAF, we now have a technology that harnesses ambient light to directly restore the molecule that dry eye disease depletes. It is almost surreal when thinking of a possible future reality where human cells can have some limited but beneficial form of photosynthetic ability.— Associate Professor David Leong Tai Wei, NUS
La Conversación del Hearth Otra perspectiva de la historia
Why the eye? Why not start with a different organ?
The eye is one of the few places in the human body that naturally absorbs visible light. It made sense to test the idea somewhere light already goes. Plus, dry eye disease is a massive problem affecting billions of people, and existing treatments have real limitations.
So you're essentially giving human cells a plant superpower.
In a very limited way, yes. We're not turning people into photosynthesizers. We're borrowing one specific part of the photosynthetic machinery—the part that makes NADPH when light hits it—and using that one molecule to break a disease cycle.
The sea slug does something similar, right? It steals chloroplasts from algae.
Exactly. That was the inspiration. If a sea slug can do it, we thought, why not explore whether mammalian cells could acquire some limited photosynthetic ability? The eye seemed like the logical place to start.
What happens if someone uses LEAF in a dark room?
It won't work without light. That's actually a feature, not a bug. The treatment is powered by the same light that enables vision. No external device needed. Just ambient light—indoor lighting is enough.
And it outperformed the existing drug in five days?
In preclinical trials, yes. The standard treatment took longer to achieve the same level of corneal healing. But we're still in early stages. Clinical trials will tell us whether this holds up in real patients.
What's the long-term vision here?
Beyond dry eye, we think this approach could work anywhere oxidative stress overwhelms the body's defenses and light can reach the tissue. Skin conditions, retinal problems, muscle inflammation. We're even exploring ways to make this work in organs light can't reach. The principle—using photosynthetic machinery to produce protective molecules—might be much broader than just the eye.